ENGAGE - KEY TECHNOLOGY VENTURES AG

Their core work

ENGAGE is a Karlsruhe-based technology ventures firm that supports EU research projects with business development, commercialization strategy, and market access expertise. Rather than conducting core R&D, they typically join consortia as a business-side partner helping translate research outcomes into viable products and services. Their portfolio spans health diagnostics, process engineering, and eHealth — reflecting a role as a cross-sector commercialization specialist rather than a domain-specific lab. The company name and project participation pattern strongly suggest their value lies in bridging science and business.

What they specialise in

How they've shifted over time

ENGAGE's early H2020 involvement (2015-2016) focused on capacity building and eHealth business support, with projects like SlovakION and eHealth Hub showing a broad technology facilitation role. From 2017 onward, they shifted toward health diagnostics (BBDiag, AiPBAND) and industrial process engineering (SIMPLIFY), taking on more technically specific projects. The lack of early-period keywords and concentration of all keywords in later projects suggests they moved from general support roles toward more defined technical domains.

Moving from broad innovation support toward health diagnostics commercialization, particularly in AI-assisted biomarker and biosensing platforms.

How they like to work

ENGAGE never leads consortia — they join as participants, partners, or third parties, consistent with a specialist contributor role focused on business exploitation. With 75 unique partners across 14 countries from just 6 projects, they operate in large consortia and do not appear to repeat partnerships, suggesting they are brought in for specific commercialization expertise rather than long-standing R&D alliances. This makes them accessible as a business-side partner for new consortia needing exploitation planning.

Despite being a small SME, ENGAGE has built a broad European network of 75 unique partners across 14 countries through participation in large consortia. Their network is wide but not deep — many one-time collaborations rather than repeated partnerships.

What sets them apart

ENGAGE occupies the niche of a cross-sector technology ventures firm that helps research consortia plan their path to market. Unlike domain-specific SMEs that contribute technical know-how, ENGAGE brings business strategy and commercialization expertise to projects spanning health, environment, and industrial processing. For consortium builders, they offer a ready-made exploitation partner with proven H2020 experience and no competing R&D agenda.

Highlights from their portfolio

• eHealth Hub
  Largest funded project (EUR 247,125) — a European hub for eHealth business support, directly aligned with ENGAGE's commercialization mission
• AiPBAND
  Most technically rich project combining cancer diagnostics, biosensing, cloud computing, and machine learning — shows ENGAGE engaging with advanced health-tech commercialization
• SIMPLIFY
  Demonstrates cross-sector reach into industrial process intensification (ultrasound, microwave, pilot-scale), a departure from their health-focused portfolio